Qiao H - Search Results

1

STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells.

Wei Z, Jiang X, Qiao H, Zhai B, Zhang L, Zhang Q, Wu Y, Jiang H, Sun X. Wei Z, et al. Among authors: qiao h. Cell Signal. 2013 Apr;25(4):931-8. doi: 10.1016/j.cellsig.2013.01.011. Epub 2013 Jan 17. Cell Signal. 2013. PMID: 23333463

2

Downregulation of Skp2 inhibits the growth and metastasis of gastric cancer cells in vitro and in vivo.

Wei Z, Jiang X, Liu F, Qiao H, Zhou B, Zhai B, Zhang L, Zhang X, Han L, Jiang H, Krissansen GW, Sun X. Wei Z, et al. Among authors: qiao h. Tumour Biol. 2013 Feb;34(1):181-92. doi: 10.1007/s13277-012-0527-8. Epub 2012 Dec 11. Tumour Biol. 2013. PMID: 23229098

3

Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells.

Zhao D, Zhai B, He C, Tan G, Jiang X, Pan S, Dong X, Wei Z, Ma L, Qiao H, Jiang H, Sun X. Zhao D, et al. Among authors: qiao h. Cell Signal. 2014 May;26(5):1030-9. doi: 10.1016/j.cellsig.2014.01.026. Epub 2014 Jan 29. Cell Signal. 2014. PMID: 24486412

4

Downregulation of developmentally regulated endothelial cell locus-1 inhibits the growth of colon cancer.

Zou X, Qiao H, Jiang X, Dong X, Jiang H, Sun X. Zou X, et al. Among authors: qiao h. J Biomed Sci. 2009;16(1):33. doi: 10.1186/1423-0127-16-33. Epub 2008 Dec 25. J Biomed Sci. 2009. PMID: 19292890 Free PMC article.

5

Combining kallistatin gene therapy and meloxicam to treat hepatocellular carcinoma in mice.

Jiang X, Li H, Qiao H, Jiang H, Xu R, Sun X. Jiang X, et al. Among authors: qiao h. Cancer Sci. 2009 Nov;100(11):2226-33. doi: 10.1111/j.1349-7006.2009.01306.x. Epub 2009 Aug 4. Cancer Sci. 2009. PMID: 19709125 Free PMC article.

6

Therapeutic effects of matrine on primary and metastatic breast cancer.

Li H, Tan G, Jiang X, Qiao H, Pan S, Jiang H, Kanwar JR, Sun X. Li H, et al. Among authors: qiao h. Am J Chin Med. 2010;38(6):1115-30. doi: 10.1142/S0192415X10008512. Am J Chin Med. 2010. PMID: 21061465

7

Downregulating hypoxia-inducible factor-2α improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma.

He C, Sun XP, Qiao H, Jiang X, Wang D, Jin X, Dong X, Wang J, Jiang H, Sun X. He C, et al. Among authors: qiao h. Cancer Sci. 2012 Mar;103(3):528-34. doi: 10.1111/j.1349-7006.2011.02177.x. Epub 2012 Jan 13. Cancer Sci. 2012. PMID: 22145922 Free PMC article.

8

Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.

Sun XP, Dong X, Lin L, Jiang X, Wei Z, Zhai B, Sun B, Zhang Q, Wang X, Jiang H, Krissansen GW, Qiao H, Sun X. Sun XP, et al. Among authors: qiao h. FEBS J. 2014 Jan;281(1):115-28. doi: 10.1111/febs.12577. Epub 2013 Nov 18. FEBS J. 2014. PMID: 24165223 Free article.

9

Meloxicam executes its antitumor effects against hepatocellular carcinoma in COX-2- dependent and -independent pathways.

Dong X, Li R, Xiu P, Dong X, Xu Z, Zhai B, Liu F, Jiang H, Sun X, Li J, Qiao H. Dong X, et al. Among authors: qiao h. PLoS One. 2014 Mar 27;9(3):e92864. doi: 10.1371/journal.pone.0092864. eCollection 2014. PLoS One. 2014. PMID: 24675684 Free PMC article.

10

Inhibition of Akt reverses the acquired resistance to sorafenib by switching protective autophagy to autophagic cell death in hepatocellular carcinoma.

Zhai B, Hu F, Jiang X, Xu J, Zhao D, Liu B, Pan S, Dong X, Tan G, Wei Z, Qiao H, Jiang H, Sun X. Zhai B, et al. Among authors: qiao h. Mol Cancer Ther. 2014 Jun;13(6):1589-98. doi: 10.1158/1535-7163.MCT-13-1043. Epub 2014 Apr 4. Mol Cancer Ther. 2014. PMID: 24705351

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,342 results

Search Page

Filters